Literature DB >> 27285342

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents.

Arisa Haino1, Tatsuya Ishikawa1, Mineaki Seki1, Masayuki Nashimoto2.   

Abstract

TRUE gene silencing (termed after tRNase Z(L)-utilizing efficacious gene silencing) is one of the RNA-directed gene silencing technologies, which utilizes an artificial small guide RNA (sgRNA) to guide tRNA 3' processing endoribonuclease, tRNase Z(L), to recognize a target RNA. sgRNAs can be taken up by cells without any transfection reagents and can downregulate their target RNA levels and/or induce apoptosis in human cancer cells. We have screened an sgRNA library containing 156 heptamer-type sgRNAs for the effect on viability of human myeloma and leukemia cells, and found that 20 of them can efficiently induce apoptosis in at least one of the cancer cell lines. Here we present a protocol for screening of a heptamer-type sgRNA library for potential therapeutic drugs against blood cancers. The protocol includes how to construct the sgRNA library, how to assess the effect of each sgRNA on cell viability, and how to further evaluate the effective sgRNAs by flow cytometry. Around 2,000 hits would be expected to be obtained by screening the full-scale sgRNA library composed of 16,384 heptamers.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27285342      PMCID: PMC4927757          DOI: 10.3791/53879

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  22 in total

1.  Expanding the utility of heptamer-type sgRNA for TRUE gene silencing.

Authors:  Takako Sano; Masayuki Takahashi; Tadasuke Nozaki; Yoshiaki Takahashi; Masato Tamura; Masayuki Nashimoto
Journal:  Biochem Biophys Res Commun       Date:  2011-11-28       Impact factor: 3.575

2.  Intracellular mRNA cleavage by 3' tRNase under the direction of 2'-O-methyl RNA heptamers.

Authors:  Masato Tamura; Chikako Nashimoto; Noriko Miyake; Yasushi Daikuhara; Kozo Ochi; Masayuki Nashimoto
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

3.  The T loop structure is dispensable for substrate recognition by tRNase ZL.

Authors:  Hirotaka S Shibata; Hiroaki Takaku; Masamichi Takagi; Masayuki Nashimoto
Journal:  J Biol Chem       Date:  2005-04-11       Impact factor: 5.157

4.  Gene silencing by the tRNA maturase tRNase ZL under the direction of small-guide RNA.

Authors:  A Nakashima; H Takaku; H S Shibata; Y Negishi; M Takagi; M Tamura; M Nashimoto
Journal:  Gene Ther       Date:  2006-08-03       Impact factor: 5.250

5.  Screening of a heptamer-type sgRNA library for potential therapeutic agents against hematological malignancies.

Authors:  Masayuki Takahashi; Reyad A Elbarbary; Norihiro Watanabe; Atsushi Goto; Daichi Kamiya; Yoshihiro Watabe; Takayoshi Uchiyama; Miwako Narita; Masuhiro Takahashi; Yoshiaki Takahashi; Noriko Ishihara; Tatsuya Miyazawa; Tetsuo Yoshida; Mitsuoki Kawano; Masato Tamura; Masayuki Nashimoto
Journal:  Leuk Res       Date:  2014-04-05       Impact factor: 3.156

6.  RNA heptamers that direct RNA cleavage by mammalian tRNA 3' processing endoribonuclease.

Authors:  M Nashimoto; S Geary; M Tamura; R Kaspar
Journal:  Nucleic Acids Res       Date:  1998-06-01       Impact factor: 16.971

7.  Human cytosolic tRNase ZL can downregulate gene expression through miRNA.

Authors:  Reyad A Elbarbary; Hiroaki Takaku; Naoto Uchiumi; Hiroko Tamiya; Mayumi Abe; Hiroshi Nishida; Masayuki Nashimoto
Journal:  FEBS Lett       Date:  2009-09-12       Impact factor: 4.124

8.  Inhibition of vascular endothelial growth factor expression by TRUE gene silencing.

Authors:  Reyad A Elbarbary; Hiroaki Takaku; Masato Tamura; Masayuki Nashimoto
Journal:  Biochem Biophys Res Commun       Date:  2009-01-09       Impact factor: 3.575

9.  Inhibition of HIV-1 gene expression by retroviral vector-mediated small-guide RNAs that direct specific RNA cleavage by tRNase ZL.

Authors:  Yuichiro Habu; Naoko Miyano-Kurosaki; Michiko Kitano; Yumihiko Endo; Masakazu Yukita; Shigeru Ohira; Hiroaki Takaku; Masayuki Nashimoto; Hiroshi Takaku
Journal:  Nucleic Acids Res       Date:  2005-01-12       Impact factor: 16.971

10.  Growth inhibition of head and neck squamous cell carcinoma cells by sgRNA targeting the cyclin D1 mRNA based on TRUE gene silencing.

Authors:  Satoshi Iizuka; Nobuhiko Oridate; Masayuki Nashimoto; Satoshi Fukuda; Masato Tamura
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

View more
  2 in total

Review 1.  TRUE Gene Silencing.

Authors:  Masayuki Nashimoto
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

2.  The heptamer sgRNA targeting the human OCT4 mRNA can upregulate the OCT4 expression.

Authors:  Tadasuke Nozaki; Masayuki Takahashi; Tatsuya Ishikawa; Arisa Haino; Mineaki Seki; Hidetomo Kikuchi; Bo Yuan; Masayuki Nashimoto
Journal:  Biochem Biophys Rep       Date:  2021-02-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.